Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostates.
Olivier J, Stavrinides V, Kay J, Freeman A, Pye H, Ahmed Z, Carmona Echeverria L, Heavey S, Simmons LAM, Kanthabalan A, Arya M, Briggs T, Barratt D, Charman SC, Gelister J, Hawkes D, Hu Y, Jameson C, McCartan N, Punwani S, van der Muelen J, Moore C, Emberton M, Ahmed HU, Whitaker HC. Olivier J, et al. Among authors: heavey s. Prostate. 2018 Dec;78(16):1229-1237. doi: 10.1002/pros.23698. Epub 2018 Aug 2. Prostate. 2018. PMID: 30073682 Free article.
VERDICT MRI validation in fresh and fixed prostate specimens using patient-specific moulds for histological and MR alignment.
Bailey C, Bourne RM, Siow B, Johnston EW, Brizmohun Appayya M, Pye H, Heavey S, Mertzanidou T, Whitaker H, Freeman A, Patel D, Shaw GL, Sridhar A, Hawkes DJ, Punwani S, Alexander DC, Panagiotaki E. Bailey C, et al. Among authors: heavey s. NMR Biomed. 2019 May;32(5):e4073. doi: 10.1002/nbm.4073. Epub 2019 Feb 19. NMR Biomed. 2019. PMID: 30779863 Free PMC article.
PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimens.
Heavey S, Costa H, Pye H, Burt EC, Jenkinson S, Lewis GR, Bosshard-Carter L, Watson F, Jameson C, Ratynska M, Ben-Salha I, Haider A, Johnston EW, Feber A, Shaw G, Sridhar A, Nathan S, Rajan P, Briggs TP, Sooriakumaran P, Kelly JD, Freeman A, Whitaker HC. Heavey S, et al. Prostate. 2019 May;79(7):768-777. doi: 10.1002/pros.23782. Epub 2019 Feb 26. Prostate. 2019. PMID: 30807665 Free PMC article.
VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.
Johnston EW, Bonet-Carne E, Ferizi U, Yvernault B, Pye H, Patel D, Clemente J, Piga W, Heavey S, Sidhu HS, Giganti F, O'Callaghan J, Brizmohun Appayya M, Grey A, Saborowska A, Ourselin S, Hawkes D, Moore CM, Emberton M, Ahmed HU, Whitaker H, Rodriguez-Justo M, Freeman A, Atkinson D, Alexander D, Panagiotaki E, Punwani S. Johnston EW, et al. Among authors: heavey s. Radiology. 2019 May;291(2):391-397. doi: 10.1148/radiol.2019181749. Epub 2019 Apr 2. Radiology. 2019. PMID: 30938627 Free PMC article.
PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.
Luszczak S, Kumar C, Sathyadevan VK, Simpson BS, Gately KA, Whitaker HC, Heavey S. Luszczak S, et al. Among authors: heavey s. Signal Transduct Target Ther. 2020 Jan 31;5(1):7. doi: 10.1038/s41392-020-0109-y. Signal Transduct Target Ther. 2020. PMID: 32296034 Free PMC article. Review.
Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer.
Li L, Hobson L, Perry L, Clark B, Heavey S, Haider A, Sridhar A, Shaw G, Kelly J, Freeman A, Wilson I, Whitaker H, Nurmemmedov E, Oltean S, Porazinski S, Ladomery M. Li L, et al. Among authors: heavey s. Br J Cancer. 2020 Sep;123(6):1024-1032. doi: 10.1038/s41416-020-0951-2. Epub 2020 Jun 25. Br J Cancer. 2020. PMID: 32581342 Free PMC article.
60 results